Approval for production of "domestic Viagra" sildenafil citrate in Baiyunshan within a month

According to the website of the State Food and Drug Administration (CFDA) on June 11, the status of "Viagra" (sildenafil citrate) applied for production by Baiyunshan has become "under examination and approval", and the company is expected to obtain the production approval document within month, becoming the first domestic listed Viagra generic drug enterprise after the expiration of the original research drug Viagra patent Viagra is Pfizer's star drug, a heavy bomb used to treat male sexual dysfunction (ED) In 2012, Viagra's sales in China have reached 1 billion yuan, and its patent in China will expire in July this year At that time, generic drugs can be listed At present, a number of enterprises have started the imitation program, and Baiyunshan is expected to take the lead According to some research reports, anti ed drugs are mainly sold through OTC channels, while Baiyunshan is competitive in OTC and prescription drug channels, unlike most enterprises only selling prescription drugs Li Chuyuan, chairman of Guangyao group, has previously said that the online release of prescription drug sales will be conducive to the promotion of domestic Viagra At present, there are nearly 10 companies competing with Baiyunshan to imitate Viacom in the same period, including Changshan pharmaceutical, Lepu medical, Haiwang biology and Lianhuan pharmaceutical